Excellent info. Thank you! For reference only:
Post# of 72440
Posted On: 07/11/2016 1:48:51 PM
Excellent info. Thank you!
Quote:
For reference only: It took eight months for The Medicines Company to reach a SPA agreement with the FDA. Both Oritavancin and Brilacidin are single-dose treatments for ABSSSI with QIDP designation.
Oritavancin SPA application date: March 26, 2010
www.accessdata.fda.gov/drugsatfda_docs...00MedR.pdf
Oritavancin SPA agreement date: November 30, 2010
http://www.firstwordpharma.com/node/809053#axzz4ABcs9svI
Brilacidin SPA application date: February 26, 2016
http://cellceutix.com/cellceutix-submits-spec...VzXCm.dpbs
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼